Re­cur­sion’s $200M of­fer­ing; Sanofi in­vests $40M in Vig­il Neu­ro­science

Plus, news about 2sev­en­ty, No­vo Nordisk, CASI, Cal­ciMed­ica, X4, NeOnc, ANI, Al­imera, Holoclara, Nx­era, Fu­ture Pak, Van­da and Bay­er:

Re­cur­sion Phar­ma­ceu­ti­cals is sell­ing $200M in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER